ALTEOGEN INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 265,000 KRW | -1.30% |
|
-1.49% | +169.04% |
| 2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
| 2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 10.17B | ||||||
| 92.38B | ||||||
| 37.9B | ||||||
| 33.73B | ||||||
| 27.98B | ||||||
| 15.86B |
- Stock Market
- Equities
- A196170 Stock
- Charts ALTEOGEN Inc.
- Sector Chart
